We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Lecithin Found to Help Modulate Lipid Metabolism

By LabMedica International staff writers
Posted on 12 Aug 2009
An endogenous phospholipid and food additive from the lecithin family has been found to activate peroxisome proliferator-activated receptors (PPAR), a class of intracellular receptors that modulate carbohydrate and fat metabolism and adipose tissue differentiation. More...
Activating PPARs induces the transcription of a number of genes that facilitate lipid metabolism.

Investigators from Washington University School of Medicine (St. Louis, MO, USA) genetically engineered a line of mice to lack the gene for the enzyme fatty acid synthase (FAS). Results published in the July 30, 2009, online issue of the journal Cell revealed that these mice had lower fasting insulin levels than normal animals and were prone to develop fatty liver disease. These were the same indications that coincided with impaired PPAR-alpha expression.

While it was known that fibrate drugs could activate PPAR-alpha and restore normal lipid metabolism, the investigators sought an endogenous ligand that could perform the same function. To this end, they used mass spectroscopy and gene expression analysis to demonstrate that the lecithin component phosphatidylcholine (1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine) could bind to and activate PPAR-alpha. This finding was confirmed by showing that "knockdown” of the Cept1 gene, required for phosphatidylcholine synthesis, suppressed PPAR-alpha-dependent gene expression.

"To our surprise, animals missing fatty acid synthase in the liver were just like animals that could not make PPAR-alpha. They had lower fasting insulin levels, and they were prone to develop fatty liver disease,” explained senior author Dr. Clay F. Semenkovich, professor of endocrinology, metabolism, and lipid research at Washington University School of Medicine. "When we gave the animals fibrate drugs that activated PPAR-alpha, the mice returned to normal, leading us to suspect that fatty acid synthase also was involved in the activation of PPAR-alpha. Although we knew that fibrate drugs would regulate PPAR-alpha, we also knew that our ability to regulate the metabolism of fats and sugars was in place long before humans started making drugs. But until now, no one had identified how it worked.”

Related Links:
Washington University School of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

Accurate, scalable diagnostics are becoming increasingly important as disease-modifying therapies reshape Alzheimer’s disease care, yet many patients still rely on invasive cerebrospinal fluid sampling... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.